Patients on H2-receptor antagonists--are we investigating them?

A E Gilliland, K A Mills, W G Irwin, K Steele

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)


A survey was made of patients receiving H2-receptor antagonists in a group practice serving 8600 patients. Two hundred and twelve patients (2%) who had received at least one prescription for H2 antagonists in a 12 month period were identified. When compared with the practice population, men and patients over 50 years old were more likely to be taking these drugs (P less than 0.01 and P less than 0.001, respectively). One hundred and fifty-seven patients (74%) were investigated before commencing therapy; 114 (73%) of these patients were investigated via the hospital outpatient department, despite the general practitioners having full open access to barium meals. Only 23 (15%) of the patients investigated were found to have no active pathology. Twenty-nine (14%) of the 212 study patients had received one or more gastrointestinal investigations in the 18 months subsequent to starting H2-antagonist therapy. Twenty-five of these patients had also received an investigation before starting therapy. One hundred and eleven patients (52%) had had their H2 antagonist therapy initiated by their general practitioner.
Original languageEnglish
Pages (from-to)43-6
Number of pages4
JournalFamily Practice
Issue number1
Publication statusPublished - 1990


Dive into the research topics of 'Patients on H2-receptor antagonists--are we investigating them?'. Together they form a unique fingerprint.

Cite this